中华医学遗传学杂志
中華醫學遺傳學雜誌
중화의학유전학잡지
CHINESE JOURNAL OF MEDICAL GENETICS
2010年
5期
512-516
,共5页
杨奕清%汤永庆%刘兴元%林小平%陈义汉
楊奕清%湯永慶%劉興元%林小平%陳義漢
양혁청%탕영경%류흥원%림소평%진의한
先天性心脏病%GATA4基因%转录因子%突变
先天性心髒病%GATA4基因%轉錄因子%突變
선천성심장병%GATA4기인%전록인자%돌변
congenital heart disease%GATA4 gene transcriptional factor%mutation
目的 研究GATA4基因新突变导致先天性室间隔缺损(ventricular septal defect,VSD)的分子机制.方法 收集185例先天性VSD患者的临床资料和血标本,以200名健康者为对照.应用PCR扩增GATA4基因的全部外显子,采用双脱氧核苷链末端合成终止法对全部扩增片段进行测序以识别基因突变.克隆GATA4基因,通过定位诱变获得相应的突变体,应用脂质体将GATA4基因重组表达质粒及心房利钠肽基因启动子启动绿色荧光蛋白表达的报告载体转染HeLa细胞,应用逆转录-PCR研究GATA4基因突变对其编码的转录因子的活性的影响.结果 在1例VSD患者的GATA4基因发现1个新的杂合错义突变c.191G>A,即第64位的密码子由GGA变为GAA,导致第64位的甘氨酸变为谷氨酸,即G64E突变.细胞表达分析显示GATA4突变G64E使转录因子的活性降低.结论 在先天性VSD患者发现GATA4新突变G64E,该突变可能通过抑制转录因子的活性而参与先天性VSD.
目的 研究GATA4基因新突變導緻先天性室間隔缺損(ventricular septal defect,VSD)的分子機製.方法 收集185例先天性VSD患者的臨床資料和血標本,以200名健康者為對照.應用PCR擴增GATA4基因的全部外顯子,採用雙脫氧覈苷鏈末耑閤成終止法對全部擴增片段進行測序以識彆基因突變.剋隆GATA4基因,通過定位誘變穫得相應的突變體,應用脂質體將GATA4基因重組錶達質粒及心房利鈉肽基因啟動子啟動綠色熒光蛋白錶達的報告載體轉染HeLa細胞,應用逆轉錄-PCR研究GATA4基因突變對其編碼的轉錄因子的活性的影響.結果 在1例VSD患者的GATA4基因髮現1箇新的雜閤錯義突變c.191G>A,即第64位的密碼子由GGA變為GAA,導緻第64位的甘氨痠變為穀氨痠,即G64E突變.細胞錶達分析顯示GATA4突變G64E使轉錄因子的活性降低.結論 在先天性VSD患者髮現GATA4新突變G64E,該突變可能通過抑製轉錄因子的活性而參與先天性VSD.
목적 연구GATA4기인신돌변도치선천성실간격결손(ventricular septal defect,VSD)적분자궤제.방법 수집185례선천성VSD환자적림상자료화혈표본,이200명건강자위대조.응용PCR확증GATA4기인적전부외현자,채용쌍탈양핵감련말단합성종지법대전부확증편단진행측서이식별기인돌변.극륭GATA4기인,통과정위유변획득상응적돌변체,응용지질체장GATA4기인중조표체질립급심방리납태기인계동자계동록색형광단백표체적보고재체전염HeLa세포,응용역전록-PCR연구GATA4기인돌변대기편마적전록인자적활성적영향.결과 재1례VSD환자적GATA4기인발현1개신적잡합착의돌변c.191G>A,즉제64위적밀마자유GGA변위GAA,도치제64위적감안산변위곡안산,즉G64E돌변.세포표체분석현시GATA4돌변G64E사전록인자적활성강저.결론 재선천성VSD환자발현GATA4신돌변G64E,해돌변가능통과억제전록인자적활성이삼여선천성VSD.
Objective To identify the GATA4 gene mutation of congenital ventricular septal defect (VSD) and study the molecular mechanism of a novel mutation. Methods The clinical data and blood samples from 185 unrelated subjects with congenital VSD were collected and evaluated together with 200 healthy individuals. The coding exons and the flanking intron regions of the GATA4 gene were amplified by PCR and sequenced using the di-deoxynucleotide chain termination approach. The GATA4 gene was cloned and the corresponding mutant was acquired by site directed mutagenesis. The recombinant plasmid expressing GATA4 and the reporter vector expressing enhanced green fluoresence protein (EGFP) driven by the promoter of atrial natrium peptide (ANP) gene were transfected into HeLa cells with Lipofectamine. The effect of mutated GATA4 gene on the transcriptional activity of encoded transcriptional factor was analyzed by reverse transcription (RT)-PCR. Results A novel heterozygous missense GATA4 mutation, c. 191G>A was identified in 1 VSD patient. The mutation leads to glycine to glutamic acid change at amino acid residue 64 (G64E) in the GATA4 protein. Functional analysis showed that GATA4 G64E mutation decreased the transcriptional activity of GATA4 transcriptional factor. Conclusion A novel heterozygous missenseGATA4 mutation, G64E, was identified in 1 VSD patient. The mutation might cause VSD by impairing the transcriptional activity of GATA4 transcriptional factor.